Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/LA/Shreveport
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Shreveport, LA

Studies commonly pay $75 to $4,500 per completed study

165 clinical trials are currently recruiting participants within 30 miles of Shreveport. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

165studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Shreveport right now

Top 25 of 165 recruiting studies, sorted by proximity — each links to its official registry page

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Shreveport, Louisiana (4.9 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Shreveport, Louisiana (4.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 710 participants sought
Trials365 LLC — Shreveport, Louisiana (4.9 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07022483)

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

Acute Myeloid Leukemias Phase 3 Interventional 468 participants sought
Clinical Trial Site — Shreveport, Louisiana (4.9 mi) · Sponsor: Syndax Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07211958)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Shreveport, Louisiana (4.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Louisiana State University Health Sciences Shreveport ( Site 0029) — Shreveport, Louisiana (4.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial

Obesity N/A Interventional 522 participants sought
David Raines Community Health Center - Shreveport Clinic — Shreveport, Louisiana (4.9 mi) · Sponsor: Tulane University
See eligibility & contact on ClinicalTrials.gov (NCT06835686)

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Epithelial Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 140 participants sought
Trials 365 /ID# 274310 — Shreveport, Louisiana (4.9 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06890338)

Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility

Normal and Diseased Tissue and Body Fluids Samples N/A Observational 100,000 participants sought
Louisiana State University Health Sciences Center — Shreveport, Louisiana (4.9 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT01354002)

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

Degenerative Disc Disease (DDD) N/A Interventional 225 participants sought
Spine Institute of Louisiana (The Spine Network) — Shreveport, Louisiana (4.9 mi) · Sponsor: ReGelTec, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06011551)

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Sickle Cell Disease Phase 3 Interventional 192 participants sought
Louisiana State University Health Sciences Center - Shreveport- Site Number : 8400037 — Shreveport, Louisiana (4.9 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT06975865)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Shreveport, Louisiana (4.9 mi) · Sponsor: Medtronic
See eligibility & contact on ClinicalTrials.gov (NCT00271180)

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

HER2-positive Breast Cancer, Breast Cancer Phase 2 Interventional 125 participants sought
LSU Health Sciences Center — Shreveport, Louisiana (4.9 mi) · Sponsor: Jazz Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07102381)

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 700 participants sought
LSU Health Feist Weiller Cancer Center — Shreveport, Louisiana (4.9 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07518186)

A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

Complicated Intra-abdominal Infections (cIAI) Phase 2 Interventional 35 participants sought
Children's Hospital of LSU Health Sciences Center Shreveport — Shreveport, Louisiana (4.9 mi) · Sponsor: Tetraphase Pharmaceuticals, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06794541)

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

Guillain-Barre Syndrome Phase 3 Interventional 30 participants sought
Ochsner LSU Health — Shreveport, Louisiana (4.9 mi) · Sponsor: Annexon, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07020819)

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus Phase 4 Interventional 350 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT06411249)

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Obesity Phase 3 Interventional 1,200 participants sought
Kailera Clinical Site — Shreveport, Louisiana (4.9 mi) · Sponsor: Kailera
See eligibility & contact on ClinicalTrials.gov (NCT07284979)

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

Peripheral Artery Disease (PAD) Phase 3 Interventional 7,050 participants sought
Cardiovascular Solutions — Shreveport, Louisiana (4.9 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07318610)

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

Pneumococcal Disease Phase 3 Interventional 1,200 participants sought
LSU Health Shreveport Clinical Trials Office — Shreveport, Louisiana (4.9 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07660198)
Actively enrolling

Studies you may be able to join near Shreveport

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Shreveport

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

La Research Center

★ 5.0
3217 Mabel St, Shreveport, LA 71103
(318) 525-3233
"Very clean facility. Helpful staff.<br>I appreciate their professionalism when dealing with nervous patients like myself."
— Lana Roberts, 5★

Clinical Research - Willis-Knighton Physician Network

1202 Louisiana Ave, Shreveport, LA 71101
(318) 212-8130

Feist-Weiller Cancer Center

★ 5.0
1501 Kings Hwy, Shreveport, LA 71103
(318) 212-9440
"I’m a past Breast Cancer survivor 2016. I was treated at Feist-Weiller. The staff were respectful, courteous, and friendly. All my questions were ans…"
— Patricia Williams, 5★

BRF

★ 4.6
2031 Kings Hwy, Shreveport, LA 71103
(318) 716-4100

Willis Knighton North

★ 3.2
2600 Greenwood Rd, Shreveport, LA 71103
(318) 212-4000
"They straight ignored my husbands notarized living will. Refused to give me his records as so specified on the living will. Directly due to the Dr ri…"
— E Tc, 1★

Lsu Health Sciences Center Ors

1501 Kings Hwy, Shreveport, LA 71103
(318) 675-6181

Louisiana Research Center, LLC

★ 1.0
1800 E 70th St, Shreveport, LA 71105
(318) 525-3233
"After signing in, waited 45 minutes in the waiting room - sitting in full view of two receptionists - finally told the receptionist to take me off th…"
— Debra Merritt, 1★

LSU Health Shreveport

★ 3.5
1501 Kings Hwy, Shreveport, LA 71103
"Once a week I make the trip here"
— Shea Williams, 3★

Willis Knighton Cancer Center

★ 4.1 (33 reviews)
2600 Kings Hwy, Shreveport, LA 71103
(318) 212-8300
"The doctor I used is phenomenal... as for the billing department... what a joke. I left 4 voicemails over a 1 month period... no response. Just a bil…"
— Richard Hummel, 1★

Clinical trials in Shreveport: what's recruiting

The Shreveport area currently has 165 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Shreveport, the most active research areas are:

  • Cancer & Oncology11 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular1 studies
  • Brain & Mental Health1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Shreveport, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Shreveport

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Shreveport participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Shreveport pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Shreveport?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Shreveport, LA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Shreveport?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Shreveport?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Shreveport.

Paid clinical trials near Shreveport

Other metros within reach

Lake Charles, LA30 Beaumont, TX44 Little Rock, AR505 Mesquite, TX1,767 Lafayette, LA58 Garland, TX1,826 McKinney, TX453 Dallas, TX1,864

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Shreveport Bladder Issues Due To Spinal Cord Injury in Shreveport All conditions

More of LA

New Orleans556 Metairie527 Baton Rouge224 Lafayette58 Lake Charles30

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts